P09.36 A new therapeutic strategy for newly diagnosed glioblastoma patients: hypofractionated stereotactic radiation therapy (HSRT) delivered in 15 fractions respect to standard fractionation in 30 fractions, with concomitant temozolomide chemotherapy - A phase II study

Introduction: The standard of care, for newly diagnosed glioblastoma multiforme (GBM), consists of surgical resection, followed by radiotherapy with concurrent and adjuvant Temozolomide. Results are still unsatisfactory. Aim of this prospective study was to evaluate outcome of newly diagnosed GBM pa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Navarria, P., Pessina, F., Tomatis, S., Simonelli, M., Santoro, A., Ascolese, A., Clerici, E., Rossi, M., Bello, L., Scorsetti, M.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
POSTER PRESENTATIONS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.292
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires